Successful pregnancy outcome with the use of antenatal high-dose intravenous immunoglobulin following previous neonatal death associated with neonatal haemochromatosis.
Nicholl
Michael C
MC
University of Sydney, Royal North Shore Hospital, St Leonards, New South Wales, Australia. mnicholl@nsccahs.health.nsw.gov.au
D000293:Adolescent; D005260:Female; D005315:Fetal Diseases / Q000517:prevention & control*; D006432:Hemochromatosis / Q000517:prevention & control; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D007231:Infant, Newborn; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011256:Pregnancy Outcome; D018566:Pregnancy, High-Risk / Q000187:drug effects*; D011295:Prenatal Care; D017584:Reproductive History
D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors